Punjab-based drugmaker QP Pharmachem Ltd has been directed to halt all manufacturing activity after the World Health Organisation (WHO) iss...

The alert was issued for a batch of substandard (contaminated) Guaifenesin Syrup TG Syrup. The substandard product was identified in the Ma...

The volumes were tepid in January, but with flu, Covid-19 and other viral infections spreading fast, February and March saw spikes in volum...

The Hyderabad-based firm plans to invest in a new manufacturing facility and on expanding production capacities at existing plants.

The scrip had four 'buy', three 'outperform', one 'underperform' but no 'sell' rating on the publicly available Reuters Eikon database as o...

Sensex dropped 106 points to close at 41,460, while Nifty dipped 0.22% to settle at 12,175.

Granules India stock was trading at Rs 162.65 apiece, up 2.07 per cent, on the BSE.

The investor relations team at Granules India denied the promoters are seeking to sell their stake.

The company has received final approval from the United States Food and Drug Administration (USFDA) to manufacture its generic Guaifenesin ...

OTC Guaifenesin and Pseudoephedrine HCl is used to help loosen phlegm (mucus) and thin bronchial secretions.

The brokerage has set a one-year horizon for the stock to hit the target price.

ET Wealth identifies nine lesser-known stocks that hold promise and can generate high returns in 2018 even as markets rise and valuations z...

Gains seen on domestic indices were in tandem with other Asian markets that hit a decade high.

Improved revenue, focus on consolidating its overseas presence and valuations at a discount to peers has made Granules India analysts’ favo...

Granules India that engages in manufacturing and supplying active pharmaceutical ingredients will expand its API and pharmaceutical formula...